Product image of Goldastatin (Simvastatin) supplied by GNH India

Goldastatin

Active Ingredient:
Simvastatin
Origin:
EU

Goldastatin (Simvastatin)

Goldastatin is a prescription medication that contains the active ingredient simvastatin, a member of the HMG‑CoA reductase inhibitor class. It is marketed in the European Union and is intended for oral administration. While the specific dosage strength and tablet form are not detailed here, Goldastatin follows the same pharmacological profile as other simvastatin products, acting to lower blood cholesterol levels and improve cardiovascular risk management.

Manufacturer / TM Owner

Panagiotis Leon & Co

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Goldastatin is indicated for the management of elevated lipid levels and related cardiovascular risk.

  • Hypercholesterolemia (primary or secondary)
  • Primary hyperlipidemia
  • Heterozygous familial hypercholesterolemia
  • Prevention of cardiovascular events in patients with established risk factors
  • Adjunct therapy combined with diet and lifestyle modifications

Side Effects

The safety profile of Goldastatin reflects that of simvastatin, with side effects ranging from mild to rare but serious.

Common

  • Muscle aches or weakness (myalgia)
  • Headache
  • Nausea or abdominal discomfort
  • Diarrhea
  • Asymptomatic elevation of liver enzymes

Serious

  • Rhabdomyolysis (severe muscle breakdown)
  • Acute kidney injury secondary to muscle breakdown
  • Severe liver injury (hepatitis)
  • Allergic reactions such as rash or angioedema

Precautions & Warnings

Before prescribing Goldastatin, clinicians should evaluate several safety considerations to minimize risk.

  • Contraindicated in pregnancy (Category X) and lactation
  • Not recommended for patients with active liver disease or unexplained persistent elevations of transaminases
  • Caution in patients with renal impairment, especially when using high doses
  • Assess for drug interactions that increase simvastatin plasma levels
  • Monitor lipid profile and liver function tests periodically
  • Use the lowest effective dose to achieve target LDL reduction

Avoid Interactions

Goldastatin can interact with other medicines, affecting its concentration and safety.

Avoid

  • Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole, HIV protease inhibitors)
  • Certain fibrates (gemfibrozil) that raise risk of muscle toxicity
  • Danazol and nefazodone

Use with caution

  • Other CYP3A4 substrates (e.g., calcium channel blockers, certain statins)
  • Antacids that may affect absorption
  • Grapefruit juice

Frequently Asked Questions

Goldastatin contains simvastatin, an HMG‑CoA reductase inhibitor that reduces cholesterol synthesis in the liver.

Goldastatin is classified as a lipid‑lowering agent within the HMG‑CoA reductase inhibitor drug class.

Goldastatin is prescribed for hypercholesterolemia, primary hyperlipidemia, familial hypercholesterolemia, and for reducing the risk of cardiovascular events in at‑risk patients.

Goldastatin is contraindicated in pregnancy (Category X) because simvastatin may cause fetal harm.

Goldastatin competitively inhibits HMG‑CoA reductase, decreasing hepatic cholesterol synthesis and increasing LDL‑receptor expression, which enhances removal of LDL from the bloodstream.

Common side effects include muscle aches or weakness, headache, nausea or abdominal discomfort, diarrhea, and mild elevations in liver enzymes.

Serious reactions can include rhabdomyolysis, acute kidney injury related to muscle breakdown, severe liver injury, and allergic responses such as rash or angioedema.

Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole), gemfibrozil, danazol, and nefazodone should be avoided because they increase the risk of muscle toxicity.

Caution is advised with other CYP3A4 substrates (such as certain calcium channel blockers), antacids that may affect absorption, and grapefruit juice, which can raise simvastatin levels.

Periodic monitoring of lipid profile, liver function tests (ALT, AST), and, when indicated, creatine kinase levels is recommended to assess efficacy and safety.

Goldastatin is a prescription‑only medication and is not available without a healthcare provider’s authorization.

Goldastatin is taken orally and can be administered with or without food, but consistent timing relative to meals helps maintain stable drug levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Simvastatin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT